SOFT TISSUE SARCOMA (STS)
Clinical trials for SOFT TISSUE SARCOMA (STS) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (STS) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (STS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to control advanced sarcoma
Disease control Not yet recruitingThis study tests a new drug combination for people with advanced soft tissue sarcoma that has not responded to earlier treatments. The treatment includes an immunotherapy drug (epalrotokewali) plus chemotherapy (eribulin), a targeted therapy (anlotinib), and radiation. The goal i…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
New combo therapy aims to shrink rare abdominal tumors before surgery
Disease control Not yet recruitingThis study tests whether giving a short, high-dose course of radiation along with immunotherapy before surgery is safe and effective for people with retroperitoneal sarcoma, a rare cancer in the abdomen. About 28 adults whose tumors are hard to remove completely will receive this…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo therapy aims to tame aggressive sarcoma
Disease control Not yet recruitingThis study tests a new treatment plan for adults with advanced soft tissue sarcoma that cannot be removed by surgery or has spread. The treatment combines a special type of radiation with an immunotherapy drug and other supportive medicines. The goal is to see if this combination…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Glow-in-the-dark dye may help surgeons spot sarcoma during removal
Knowledge-focused Not yet recruitingThis early-stage study tests whether a fluorescent dye called 5-ALA can help surgeons see soft tissue sarcoma tumors more clearly during surgery. About 20 adults with grade 2 or 3 sarcoma will take the dye by mouth before their operation. The main goal is to see if the dye makes …
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC